Efficacy and safety of concurrent anti-Cancer and anti-tuberculosis chemotherapy in Cancer patients with active Mycobacterium tuberculosis: a retrospective study

BACKGROUND: In our previous study, colorectal cancer (CRC) patients with active Mycobacterium tuberculosis (MTB) tolerated concurrent anti-cancer chemotherapy (anti-CCT) and anti-MTB chemotherapy. In this study, we retrospectively confirmed the efficacy and safety of concurrent chemotherapy in a gre...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirashima, Tomonori, Tamura, Yoshitaka, Han, Yuki, Hashimoto, Shoji, Tanaka, Ayako, Shiroyama, Takayuki, Morishita, Naoko, Suzuki, Hidekazu, Okamoto, Norio, Akada, Shinobu, Fujishima, Makoto, Kadota, Yoshihisa, Sakata, Kazuya, Nishitani, Akiko, Miyazaki, Satoru, Nagai, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186130/
https://www.ncbi.nlm.nih.gov/pubmed/30314434
http://dx.doi.org/10.1186/s12885-018-4889-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186130/
https://www.ncbi.nlm.nih.gov/pubmed/30314434
http://dx.doi.org/10.1186/s12885-018-4889-1

Ejemplares similares